Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer

Clinical trial NCT01707823 · TERMINATED

Trial details

NCT number: NCT01707823
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Adenocarcinoma of the Lung Recurrent Non-small Cell Lung Cancer Stage IA Non-small Cell Lung Cancer Stage IB Non-small Cell Lung Cancer Stage IIA Non-small Cell Lung Cancer Stage IIB Non-small Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer

Start date: 2012-10-01
Primary completion: 2018-06-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.